Related Experiment Video
Updated: Feb 15, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Data sharing in clinical trials - practical guidance on anonymising trial datasets
Catriona Keerie1, Christopher Tuck2, Garry Milne2
1Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Nine Bioquarter, 9 Little France Road, Edinburgh, EH16 4UX, UK. catriona.keerie@ed.ac.uk.
Trialists can now share anonymised data following new practical guidelines. This ensures participant privacy while meeting funder demands for data access after primary analysis.
Area of Science:
- Clinical Trials Methodology
- Data Management
- Health Informatics
Background:
- Increasing demand from non-commercial funders for trial data access post-primary analysis.
- Need to balance data sharing with participant confidentiality, legal, and regulatory requirements.
Purpose of the Study:
- To provide practical guidance on anonymising clinical trial datasets.
- To develop a controlled access model for sharing anonymised trial data.
Main Methods:
- Anonymisation of a recently completed trial dataset using Medical Research Council Hubs for Trials Methodology Research (MRC HTMR) guidelines.
- Classification of variables into direct, indirect, and superfluous identifiers with tailored anonymisation methods.
- Implementation of a controlled access model and data release procedure.
Main Results:
- Successful creation of a controlled access model for anonymised trial data sharing.
- Development of a bespoke anonymised dataset for a completed trial.
- Established procedures for data anonymisation and release.
Conclusions:
- A practical solution for anonymising clinical trial data has been implemented.
- Learnings gained on process efficiency, balancing anonymity with data utility, and future work.
- The developed method facilitates secure trial data sharing while protecting participant privacy.
More Related Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...